Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Synthesis and characterization of the first inhibitor of N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD)..
Chem Commun (Camb). 53(95), 12814-12817.
(2017). Docetaxel and intermittent erlotinib in patients with metastatic Non-Small Cell Lung Cancer; a phase II study from the Hellenic Cooperative Oncology Group..
Anticancer Res. 34(10), 5649-55.
(2014). Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment..
Drug Des Devel Ther. 8, 1753-63.
(2014). The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected]..
Expert Opin Drug Metab Toxicol. 10(6), 787-812.
(2014). Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer..
Future Oncol. 10(2), 219-31.
(2014). A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas..
J Neurol. 260(6), 1469-80.
(2013). Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer..
J Exp Clin Cancer Res. 31, 77.
(2012).